
|Videos|February 14, 2022
Building Resilience in US Medicine Supply Chain Can Bolster Preparedness for What May Come During the Pandemic
Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how building resilience in the medicine supply chain will help bolster preparedness for what may arise during the COVID-19 pandemic and beyond.
Advertisement
Pharmacy Times interviewed Ronald T. Piervincenzi, CEO of US Pharmacopeia (USP), on a recent USP survey that showed 9 out of 10 physicians feel their trust in the ability of the US supply chain to deliver safe, quality medicines has eroded.
During the discussion, Piervincenzi addressed how building resilience in the medicine supply chain will help bolster preparedness for what may arise during the COVID-19 pandemic and beyond.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
3
Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer
4
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
5




























































































































